Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) (NCT07011589)
🩺 Plain-English Summary (8th-Grade Level)
The study objective is to see if IV Efgartigimod and Vyjuvek treatment in Recessive Dystrophic Epidermolysis Bullosa (RDEB) and IV Efgartigimod treatment in Epidermolysis Bullosa Acquisita (EBA) improves wound healing and affects the levels of C7 antibody levels in serum. Fewer wounds, more rapidly healing wounds, and decreased C7 antibodies could improve quality of life.
Who can join: Review the eligibility criteria below.
Location: Stanford University — Redwood City, California
Age range: 12 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stanford University — Redwood City, California
📞 Contact the Study Coordinator
Phone: (650) 721-4902
Email: kunju@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Epidermolysis Bullosa (EB)
- Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa — Rancho Santa Margarita, California
- A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study — Cincinnati, Ohio
Explore by condition: All Epidermolysis Bullosa (EB) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.